Indication
Cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 6 months of age with cystinosis.
Loading your page…
Loading your page…
Cystinosis
Marketing Authorisation Holder: Recordati Rare Diseases
EMA Authorisation: 18/01/2017
INN: mercaptamine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Cystadrops: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.